Relation of the Area of Cerclage With Preterm Birth
Is the Cerclage Area Associated With the Incidence of Preterm Birth in Pregnant Women Undergoing Mc Donald Cerclage?
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
The parameters that will be measured with transvaginal ultrasound are:
- Cerclage area in the axial plane of the cervix
- Angle between anterior uterine wall and internal os
- Angle between anterior uterine wall and external os
- Anterior and posterior cervical widht at level of stitch
- Anterior and posterior stitch depth (stitch to canal )
- Cervical length above and below cerclage stitch
Before the data collection phase ,the required sample number for the research was determined using the G*power (Faul, Erdfelder, Buchner, & Lang, 2009) 3.1 program. When the alpha level is .05 and the power is %95 , the total number of samples was found o be 22.
Study Type
Study Type
Enrollment (Anticipated)
Enrollment
Contacts and Locations
Study Contact
Study Contact
- Name: Neval Çayönü Kahraman, MD
- Phone Number: +905336212174
- Email: nevalcayonu@gmail.com
Study Contact Backup
- Name: Mehmet Obut, MD
- Phone Number: +905056710339
- Email: drmehmetobut@hotmail.com
Study Locations
-
-
Keçiören
-
Ankara, Keçiören, Turkey, 06010
- Recruiting
- Etlik Zübeyde Hanım Women's Health Training and Research Hospital
-
Contact:
- Neval Çayönü Kahraman, MD
- Phone Number: +905336212174
- Email: nevalcayonu@gmail.com
-
Contact:
- Mehmet Obut, MD
- Phone Number: +905056710339
- Email: drmehmetobut@hotmail.com
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Singleton pregnancy between 16-23 weeks of gestation and between the ages of 18-45
- According to ACOG based on history (Having one or more painless abortions between 16-22 weeks of gestation , a history of cerclage
- According to ACOG based on physical examination ( fetal membranes prolapsed from endocervical canal or not, cervical dilation present )
- Accoding to ACOG based on ultrasound examination ( if there is no previous history of preterm birth , if the cervical length is 10mm or less, if the cervical length is less than 25mm with a history of preterm birth )
Exclusion Criteria:
- Multiple pregnancies
- Pregnant women with premature rupture of membranes
- Pregnant women with uterine anomalies
- Pregnant women with fetal anomalies
- Pregnant women with Gestational diabetes mellitus, Chronic or gestational hypertension , fetal growth restriction , oligohydroamnios or polihydroamnios
Study Plan
How is the study designed?
Design Details
- Observational Models: Case-Only
- Time Perspectives: Prospective
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
cervical cerclage area
Time Frame: Between 16-23 weeks of pregnancy
|
cervical cerclage will be measured in the axial plane of the cervix by transvaginal ultrasonography
|
Between 16-23 weeks of pregnancy
|
|
Preterm birth
Time Frame: From date of cervical cerclage to delivery
|
The incidence of patients delivered before 37. gestational weeks
|
From date of cervical cerclage to delivery
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Study Director: Can Tekin Iskender, MD, Helath Sciences University, Etlik Zubeyde Hanım Women's Health Training and Research Hospital
Publications and helpful links
General Publications
- Kahraman N, Obut M. Area of cervical cerclage
Helpful Links
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Anticipated)
Primary Completion
Study Completion (Anticipated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 2021/132
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.